Completed
NA
INTERVENTIONAL
NCT06873438
The Effect of Probiotics on the Improvement of Intestinal and Immune Function
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
Evaluate the effectiveness and safety of Lactobacillus delbrueckii subsp. bulgaricus LB42 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.
Interventions
Name:
Probiotic group
Type:
DIETARY_SUPPLEMENT
Description:
The experimental phase of this study will last 8 weeks and each subject will receive 3 follow-up visits (week 0, week 4, week 8).
Name:
Placebo group
Type:
DIETARY_SUPPLEMENT
Description:
The experimental phase of this study will last 8 weeks and each subject will receive 3 follow-up visits (week 0, week 4, week 8).
Primary Outcomes
Measure:
Change in the concentration of LL-37 in feces before and after intervention.
TimeFrame:
Week 0 and Week 8
Description:
Detected by Enzyme-Linked Immunosorbent Assay (ELISA).
Trial Information
NCT ID
NCT06873438
Status
Completed
Study Type
INTERVENTIONAL
Phases
NA
Sponsor
Wecare Probiotics Co., Ltd.
Last Updated
December 15, 2025